1qhi

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1qhi" size="450" color="white" frame="true" align="right" spinBox="true" caption="1qhi, resolution 1.9&Aring;" /> '''HERPES SIMPLEX VIRUS ...)
Line 1: Line 1:
-
[[Image:1qhi.gif|left|200px]]<br /><applet load="1qhi" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1qhi.gif|left|200px]]<br /><applet load="1qhi" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1qhi, resolution 1.9&Aring;" />
caption="1qhi, resolution 1.9&Aring;" />
'''HERPES SIMPLEX VIRUS TYPE-I THYMIDINE KINASE COMPLEXED WITH A NOVEL NON-SUBSTRATE INHIBITOR, 9-(4-HYDROXYBUTYL)-N2-PHENYLGUANINE'''<br />
'''HERPES SIMPLEX VIRUS TYPE-I THYMIDINE KINASE COMPLEXED WITH A NOVEL NON-SUBSTRATE INHIBITOR, 9-(4-HYDROXYBUTYL)-N2-PHENYLGUANINE'''<br />
==Overview==
==Overview==
-
Treatment of herpes infections with nucleoside analogues requires as an, initial step the activation of the compounds by thymidine kinase. As an, aid to developing more effective chemotherapy, both for treatment of, recurrent herpes infection and in gene therapy systems where thymidine, kinase is expressed, two high-resolution X-ray structures of thymidine, kinase have been compared: one with the relatively poor substrate, aciclovir (Zovirax), the other with a synthetic inhibitor having an, N2-substituted guanine. Both compounds have similar binding modes in spite, of their size difference and apparently distinct ligand properties.
+
Treatment of herpes infections with nucleoside analogues requires as an initial step the activation of the compounds by thymidine kinase. As an aid to developing more effective chemotherapy, both for treatment of recurrent herpes infection and in gene therapy systems where thymidine kinase is expressed, two high-resolution X-ray structures of thymidine kinase have been compared: one with the relatively poor substrate aciclovir (Zovirax), the other with a synthetic inhibitor having an N2-substituted guanine. Both compounds have similar binding modes in spite of their size difference and apparently distinct ligand properties.
==About this Structure==
==About this Structure==
-
1QHI is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Human_herpesvirus_4 Human herpesvirus 4] with SO4 and BPG as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Thymidine_kinase Thymidine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.21 2.7.1.21] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1QHI OCA].
+
1QHI is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Human_herpesvirus_4 Human herpesvirus 4] with <scene name='pdbligand=SO4:'>SO4</scene> and <scene name='pdbligand=BPG:'>BPG</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Thymidine_kinase Thymidine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.21 2.7.1.21] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1QHI OCA].
==Reference==
==Reference==
Line 15: Line 15:
[[Category: Thymidine kinase]]
[[Category: Thymidine kinase]]
[[Category: Batuwangala, T.]]
[[Category: Batuwangala, T.]]
-
[[Category: Bennett, M.S.]]
+
[[Category: Bennett, M S.]]
-
[[Category: Champness, J.N.]]
+
[[Category: Champness, J N.]]
[[Category: Rutherford, T.]]
[[Category: Rutherford, T.]]
-
[[Category: Sanderson, M.R.]]
+
[[Category: Sanderson, M R.]]
-
[[Category: Summers, W.C.]]
+
[[Category: Summers, W C.]]
[[Category: Sun, H.]]
[[Category: Sun, H.]]
[[Category: Wien, F.]]
[[Category: Wien, F.]]
Line 29: Line 29:
[[Category: transferase (phosphotransferase) thymidine]]
[[Category: transferase (phosphotransferase) thymidine]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 00:42:03 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:39:36 2008''

Revision as of 12:39, 21 February 2008


1qhi, resolution 1.9Å

Drag the structure with the mouse to rotate

HERPES SIMPLEX VIRUS TYPE-I THYMIDINE KINASE COMPLEXED WITH A NOVEL NON-SUBSTRATE INHIBITOR, 9-(4-HYDROXYBUTYL)-N2-PHENYLGUANINE

Overview

Treatment of herpes infections with nucleoside analogues requires as an initial step the activation of the compounds by thymidine kinase. As an aid to developing more effective chemotherapy, both for treatment of recurrent herpes infection and in gene therapy systems where thymidine kinase is expressed, two high-resolution X-ray structures of thymidine kinase have been compared: one with the relatively poor substrate aciclovir (Zovirax), the other with a synthetic inhibitor having an N2-substituted guanine. Both compounds have similar binding modes in spite of their size difference and apparently distinct ligand properties.

About this Structure

1QHI is a Single protein structure of sequence from Human herpesvirus 4 with and as ligands. Active as Thymidine kinase, with EC number 2.7.1.21 Full crystallographic information is available from OCA.

Reference

Structure to 1.9 A resolution of a complex with herpes simplex virus type-1 thymidine kinase of a novel, non-substrate inhibitor: X-ray crystallographic comparison with binding of aciclovir., Bennett MS, Wien F, Champness JN, Batuwangala T, Rutherford T, Summers WC, Sun H, Wright G, Sanderson MR, FEBS Lett. 1999 Jan 25;443(2):121-5. PMID:9989588

Page seeded by OCA on Thu Feb 21 14:39:36 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools